Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing
Author(s) -
Brandon Nokes,
Hassan Raza,
Rodrigo CartinCeba,
Phillip J. Lyng,
Lois E. Krahn,
Lewis Wesselius,
Clinton Jokerst,
Sarah B. Umar,
W. Leroy Griffing,
Matthew R. Neville,
Atul Malhotra,
James M. Parish
Publication year - 2019
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8036
Subject(s) - medicine , interstitial lung disease , scleroderma (fungus) , cardiology , pulmonary function testing , pulmonary hypertension , population , prospective cohort study , sleep apnea , connective tissue disease , lung , disease , pathology , autoimmune disease , environmental health , inoculation
Scleroderma is associated with abnormal skin thickening, interstitial lung disease, pulmonary hypertension, and abnormalities of the upper airway. These changes can cause cardiopulmonary complications, potentially including sleep-disordered breathing. The objective of this study is to examine the risk of sleep-disordered breathing in patients with scleroderma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom